Holdings
Blue Owl Capital Holdings LP
As of Sep 30, 2026, Blue Owl Capital Holdings LP reported 48 positions worth US$544M. Largest: Space Exploration Technologies Corp, Aktis Oncology, Inc. and Latigo Biotherapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Space Exploration Technologies Corp | 923K | US$139M | −476K | Sep 30, 2026 |
| Aktis Oncology, Inc. | 3.34M | US$65.1M | +274K | Sep 30, 2026 |
| Latigo Biotherapeutics, Inc. | 3.6M | US$60.1M | new | Sep 30, 2026 |
| Larimar Therapeutics, Inc. | 9.92M | US$31.7M | +761K | Sep 30, 2026 |
| Electra Therapeutics, Inc. | 2.61M | US$29.4M | new | Sep 30, 2026 |
| Nuveen Churchill Direct Lending Corp. | 2.14M | US$24.1M | no change | Sep 30, 2026 |
| Cullinan Therapeutics, Inc. | 1.4M | US$21.5M | −140K | Sep 30, 2026 |
| Blue Owl Capital Corporation | 2.05M | US$21.5M | no change | Sep 30, 2026 |
| Obsidian Therapeutics, Inc. | 1.48M | US$20.4M | new | Sep 30, 2026 |
| Sagimet Biosciences Inc. - Series A | 1.13M | US$11.1M | −135K | Sep 30, 2026 |